- Presentations
- 2
- Markets
- 1
Kymriah is a brand of Tisagenlecleucel marketed by Novartis Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Tisagenlecleucel
- Brand owner
- Novartis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 2000000 injectable suspension, 60000000 injectable suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Kymriah 2000000 injectable suspensionIntravenous | Novartis Pharmaceuticals | US FDA | Available on request |
| Kymriah 60000000 injectable suspensionIntravenous | Novartis Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Kymriah
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.